SCAI expert consensus update on best practices in the cardiac catheterization laboratory
Srihari S. Naidu(All India Institute of Medical Sciences Jodhpur), Daniel M. Kolansky(Hospital of the University of Pennsylvania), Jayant Bagai(Vanderbilt University Medical Center), Kimberly A. Skelding(Wenatchee Valley College), Santiago García(Minneapolis VA Health Care System), David J. Slotwiner(Cornell University), Lorrena Kirkwood(Westchester Medical Center), Frederick G.P. Welt(Harvard University), Prashant Kaul(Piedmont Atlanta Hospital), Rajesh V. Swaminathan(Cornell University), J. Dawn Abbott(Brown University), Matheen Khuddus(The Cardiac and Vascular Institute), Sohah N. Iqbal(Salem Hospital), James C. Blankenship(University of New Mexico), Steven V. Manoukian, Manesh R. Patel(Duke University)
Cited by 64
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2011|1.3k